Understanding Uterine Polyps: Biology and Symptoms
At a Glance
Uterine polyps are usually benign growths from the uterine lining, but they can cause spotting, heavy or irregular bleeding, postmenopausal bleeding, or fertility difficulties. Any postmenopausal bleeding and very heavy bleeding should be medically evaluated.
Uterine polyps, also known as endometrial polyps, are small, finger-like growths that develop from the inner lining of the uterus (the endometrium) [1]. While they are overwhelmingly benign (non-cancerous), they can cause disruptive symptoms, trigger anxiety, or interfere with fertility [2]. Understanding how these growths form and how they differ from other common uterine issues is an important first step in managing your gynecological health.
How Polyps Form
A polyp begins as a focal overgrowth of the uterine lining [1]. Unlike the rest of the lining, which thickens and sheds every month during a period, these growths stay attached to the uterine wall by a base or a thin stalk [1].
Biologically, polyps are made of a mix of endometrial glands, connective tissue (stroma), and thick-walled blood vessels [1]. Research suggests that hormones—specifically estrogen and progesterone—play a key role in their development [3]. In many cases, polyps show a higher number of estrogen receptors and a lower number of progesterone receptors compared to the healthy surrounding tissue [3]. This hormonal imbalance may cause that specific spot to grow excessively rather than shedding normally [4].
Symptom Patterns by Life Stage
Not every polyp causes symptoms; many are found incidentally during a routine exam or an ultrasound for an unrelated reason [5]. However, when symptoms do occur, they often follow specific patterns depending on whether you have reached menopause.
- Premenopausal Women: The most characteristic symptom is intermenstrual bleeding, which is spotting or bleeding that occurs between your normal periods [2]. You may also experience heavy menstrual bleeding (menorrhagia) or irregular cycles where the timing of your period becomes unpredictable [6][7]. If you experience very heavy bleeding that causes dizziness, shortness of breath, or requires changing a pad every hour, seek prompt medical evaluation for anemia or acute blood loss.
- Postmenopausal Women: In people who have finished menopause, any vaginal bleeding is considered abnormal and should be evaluated promptly [8]. Polyps are one possible cause of postmenopausal bleeding [9]. However, a polyp’s presence does not rule out other causes, such as vaginal atrophy or cancer, so a thorough evaluation is always necessary.
- Fertility Concerns: Polyps can act like a physical barrier or cause local inflammation that makes it harder for an embryo to attach to the uterine wall, potentially leading to subfertility (difficulty getting pregnant) [2][8].
Polyps vs. Fibroids
It is common to confuse polyps with uterine fibroids (leiomyomas), but they are fundamentally different types of growths. Their symptoms can overlap significantly, so imaging is required to tell them apart.
| Feature | Uterine Polyp | Uterine Fibroid |
|---|---|---|
| Origin | Grows from the inner lining (endometrium) [1]. | Grows from the muscle of the uterine wall (myometrium) [10]. |
| Composition | Glands, stroma, and blood vessels [1]. | Dense, fibrous muscle tissue [11]. |
| Typical Size | Usually small (millimeters to a few centimeters) [12]. | Can range from tiny to the size of a grapefruit or larger [13]. |
| Typical Symptoms | Focal spotting and irregular or intermenstrual bleeding [2]. | Heavy periods, pelvic pressure, and “bulk” symptoms [13], though submucosal fibroids can also cause spotting. |
Who is at Risk?
While anyone with a uterus can develop a polyp, certain factors increase the likelihood:
- Age and Menopause: The risk generally increases as you get older, peaking in your 40s and 50s [14].
- Weight and Metabolism: Having a higher BMI (Body Mass Index), diabetes, or high blood pressure (hypertension) is linked to a higher incidence of polyps [15][5].
- Tamoxifen Use: Patients taking tamoxifen for breast cancer treatment have a significantly higher risk of developing endometrial polyps because of how the drug affects the uterine lining [16].
Prevalence: How Common Are They?
Because many polyps have no symptoms, it is hard to say exactly how many people have them in the general population. Estimates vary widely, from roughly 8% to 30% depending on the age group and the imaging tools used [17]. However, among those who seek medical help for abnormal uterine bleeding (AUB), polyps are found much more frequently—detected in approximately 34% to 38% of cases [18][19].
While the vast majority of polyps are benign, pooled studies suggest a small percentage (an average of about 3.4% across populations) may contain precancerous or cancerous cells [20][21]. This is a population average, not an individual guarantee. This risk is generally higher for postmenopausal patients or those who are experiencing active bleeding, which is why testing is highly recommended in those situations [20][12].
Common questions in this guide
What exactly is a uterine polyp, and how does it develop?
What bleeding changes can uterine polyps cause?
Does bleeding after menopause mean I have a uterine polyp?
How are uterine polyps different from fibroids?
Can a uterine polyp make it harder to get pregnant?
Are uterine polyps cancerous?
Who is more likely to develop uterine polyps?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Bleeding symptoms
Could a polyp be behind bleeding between my periods?
Other causes of bleeding
Does finding a polyp rule out other causes of my bleeding?
Fertility concerns
Could a polyp make it harder to become pregnant?
Related questions
Get notified when new evidence is published on uterine polyp.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (21)
- 1
Clinicopathological study of endometrial polyps: experience from a tertiary care center.
Al-Harthy A, Arafa M
Folia medica 2025; (67(4)) doi:10.3897/folmed.67.e153005.
PMID: 40884131 - 2
Endometrial Polyps.
Han MN, Munro MG
Obstetrics and gynecology 2026; (148(4)):489-507 doi:10.1097/AOG.0000000000006232.
PMID: 41818771 - 3
Impact of estrogen and progesterone receptor expression on the incidence of endometrial polyps.
Yan C, Xing C, Wei T, et al.
Biomarkers in medicine 2023; (17(21)):881-887 doi:10.2217/bmm-2023-0411.
PMID: 38230984 - 4
Progesterone ameliorates the endometrial polyp by modulating the signaling pathway of Wnt and β-catenin via regulating the expression of H19 and miR-152.
Feng M, Zhang T, Ma H
Journal of cellular biochemistry 2019; (120(6)):10164-10174 doi:10.1002/jcb.28301.
PMID: 30659641 - 5
To treat or not to treat? An evidence-based practice guide for the management of endometrial polyps.
Sheng KK, Lyons SD
Climacteric : the journal of the International Menopause Society 2020; (23(4)):336-342 doi:10.1080/13697137.2020.1742107.
PMID: 32496825 - 6
Uterine disorders and iron deficiency anemia.
Donnez J, Carmona F, Maitrot-Mantelet L, et al.
Fertility and sterility 2022; (118(4)):615-624 doi:10.1016/j.fertnstert.2022.08.011.
PMID: 36182260 - 7
Symptom-related Ki-67 expression in endometrial polyps.
Atak Z, Turhan EI, Rahimli Ocakoglu S, Uyaniklar OO
European journal of obstetrics, gynecology, and reproductive biology 2022; (272()):139-143 doi:10.1016/j.ejogrb.2022.03.022.
PMID: 35307614 - 8
Endometrial polyps. An evidence-based diagnosis and management guide.
Vitale SG, Haimovich S, Laganà AS, et al.
European journal of obstetrics, gynecology, and reproductive biology 2021; (260()):70-77 doi:10.1016/j.ejogrb.2021.03.017.
PMID: 33756339 - 9
Effectiveness and patient satisfaction with office hysteroscopic polypectomy in patients with symptomatic endometrial polyps.
Céspedes Martínez MA, Rovira Pampalona J, Degollada Bastos M, et al.
Facts, views & vision in ObGyn 2022; (14(4)):325-329 doi:10.52054/FVVO.14.4.045.
PMID: 36724424 - 10
Comparative transcriptomic analysis of endometrial tissue associated with uterine fibroids and endometrial polyps.
Korczyńska L, Dąbrowska M, Kulecka M, et al.
Scientific reports 2026; (16(1)).
PMID: 42259941 - 11
The Effect of Endometrial Polyp and Myoma Uteri on Fertility-Related Genes in the Endometrium.
Özbey G, Tuncay G, Düz SA, et al.
Reproductive sciences (Thousand Oaks, Calif.) 2025; (32(3)):728-737 doi:10.1007/s43032-025-01802-0.
PMID: 39915377 - 12
Guideline No. 447: Diagnosis and Management of Endometrial Polyps.
Bougie O, Randle E, Thurston J, et al.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2024; (46(3)):102402 doi:10.1016/j.jogc.2024.102402.
PMID: 38325734 - 13
Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity.
Munro MG
Fertility and sterility 2019; (111(4)):629-640 doi:10.1016/j.fertnstert.2019.02.008.
PMID: 30929720 - 14
Metabolic syndrome as a predictor of endometrial polyps in postmenopausal women.
Bueloni-Dias FN, Spadoto-Dias D, Delmanto LR, et al.
Menopause (New York, N.Y.) 2016; (23(7)):759-64 doi:10.1097/GME.0000000000000616.
PMID: 27116465 - 15
Prevalence of endometrial polyps coexisting with uterine fibroids and associated factors.
Kınay T, Öztürk Başarır Z, Fırtına Tuncer S, et al.
Turkish journal of obstetrics and gynecology 2016; (13(1)):31-36 doi:10.4274/tjod.36043.
PMID: 28913086 - 16
Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer.
Ryu KJ, Kim MS, Lee JY, et al.
JAMA network open 2022; (5(11)):e2243951 doi:10.1001/jamanetworkopen.2022.43951.
PMID: 36441547 - 17
Removal of uterine polyps: clinical management and surgical approach.
Ludwin A, Lindheim SR, Booth R, Ludwin I
Climacteric : the journal of the International Menopause Society 2020; (23(4)):388-396 doi:10.1080/13697137.2020.1784870.
PMID: 32648824 - 18
Comparison of diagnostic accuracy of saline infusion sonohysterography, transvaginal sonography, and hysteroscopy in evaluating the endometrial polyps in women with abnormal uterine bleeding: a systematic review and meta-analysis.
Kaveh M, Sadegi K, Salarzaei M, Parooei F
Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques 2020; (15(3)):403-415 doi:10.5114/wiitm.2020.93791.
PMID: 32904526 - 19
Typical ultrasound features of various endometrial pathologies described using International Endometrial Tumor Analysis (IETA) terminology in women with abnormal uterine bleeding.
Van Den Bosch T, Verbakel JY, Valentin L, et al.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2021; (57(1)):164-172 doi:10.1002/uog.22109.
PMID: 32484286 - 20
The risk of malignancy in uterine polyps: A systematic review and meta-analysis.
Uglietti A, Buggio L, Farella M, et al.
European journal of obstetrics, gynecology, and reproductive biology 2019; (237()):48-56 doi:10.1016/j.ejogrb.2019.04.009.
PMID: 31009859 - 21
Factors Associated with Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis.
Sasaki LMP, Andrade KRC, Figueiredo ACMG, et al.
Journal of minimally invasive gynecology 2018; (25(5)):777-785 doi:10.1016/j.jmig.2018.02.004.
PMID: 29454147
This page is for informational purposes only and does not constitute medical advice. A gynecologist should evaluate abnormal or postmenopausal bleeding and discuss fertility concerns in the context of your health.